ALX Oncology
ALXO
#9446
Rank
โ‚น7.43 B
Marketcap
โ‚น137.12
Share price
-1.30%
Change (1 day)
6.99%
Change (1 year)

Revenue for ALX Oncology (ALXO)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ALX Oncology from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A
2023 N/A
2022 N/A
2021 N/A-100%
2020 โ‚น86.44 M-74.72%
2019 โ‚น0.34 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA